Institutional investors are showing interest in StepStone Group, with analysts issuing reports affecting company valuation.
1 report, 1 independent
Updated Jul 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Institutional investors are showing interest in StepStone Group, with analysts issuing reports affecting company valuation.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
CVS Health
company
Related events
- Truist Financial raised its price target on CVS Health stock, with MarketBeat aggregating analyst ratings.
- ARS Pharmaceuticals Inc. was reported for misleading investors about its coverage progress.
- Truist Financial raised its target price and gave a 'buy' rating for CVS Health.
- Larry Robbins sold CVS Health shares, and Fifth Third Bancorp lifted its position in CVS Health stock, both disclosed to the SEC.